Loading
No insider purchase over the last 90 days. The latest, by 戴立忠, was filed 21 Jan 2022.
Sansure Biotech Inc.: what insiders have been doing
Every trade that managers of Sansure Biotech Inc. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Sansure Biotech Inc. The previous disclosure was published on 21 January 2022.
Over the whole record (from 2021), the tally stands at 1 purchase and 1 sale.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€1M
1 ops. · all time
Sell Volume
€7M
1 ops. · all time
Since the insiders bought
- -38.3%Entry CN¥37.55 · Close at T+365 CN¥23.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,920 of 24,166 companies
44.3
score / 100
Value30
Quality59
FCF yld-2.0%
Earn yld2.1%
EV/EBITDA25.8x
ROE1.3%
Gross mgn76%
Net mgn12%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥16.49
Analyst consensus
1 analystsCN¥22.02Target CN¥22.02(+34%)CN¥22.02
Income statement
RevenueCN¥1.6B
Gross profitCN¥1.2B76% margin
EBITDACN¥410.8M25% margin
Net incomeCN¥198.9M8.4% margin
Valuation
PER (trailing)71.7x
P/Book1.3x
Beta0.44
Balance sheet & cash
Market capCN¥9.5B
Total debtCN¥1.1B
Free Cash Flow-CN¥185.8M
Debt / Equity22%
Profitability & ownership
ROE1.3%
ROA0.2%
% insiders47.4%
% institutions6.0%
Last declaration on 21 January 2022
About Sansure Biotech Inc.
圣湘生物 is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for diagnosis and treatment. It is listed on the Shanghai Stock Exchange under the symbol XSHG.
